SHIRLEY FRIEH: Open Payments
NPI 1326421702 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 116 payments from 13 companies in 2025. Trend: 2023 $2,388 · 2024 $1,806 · 2025 $1,774
Food & beverage: $1,774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $459 |
| Neurocrine BioSciences, Inc. | 13 | $236 |
| Otsuka America Pharmaceutical, Inc. | 15 | $234 |
| Vanda Pharmaceuticals Inc. | 7 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $180 |
| Axsome Therapeutics, Inc. | 6 | $125 |
| Alkermes, Inc. | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| Biogen, Inc. | 1 | $21 |
Products named: VRAYLAR, REXULTI, INGREZZA, FANAPT, CAPLYTA, Auvelity, ARISTADA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
